Christopher Durant Turner, Chief Medical Officer at Nuvalent, Inc. (NUVL), sold 20,470 shares at $44.86 ($918K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Scheduled sale ($918k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.86 | 10,235 | $459K | 50.0% |
| 2 | $44.86 | 10,235 | $459K | 50.0% |
| Total | $44.86 avg | 20,470 | $918K | 100% |
| Filing → |
| NUVL | SELL | 2023-10-06 | $775K | — | Filing → |
| NUVL | SELL | 2023-07-28 | $482K | — | Filing → |
| NUVL | SELL | 2023-07-24 | $14K | — | Filing → |